Page last updated: 2024-09-05

bw a522 and 1,3-dipropyl-8-(4-sulfophenyl)xanthine

bw a522 has been researched along with 1,3-dipropyl-8-(4-sulfophenyl)xanthine in 1 studies

Compound Research Comparison

Studies
(bw a522)
Trials
(bw a522)
Recent Studies (post-2010)
(bw a522)
Studies
(1,3-dipropyl-8-(4-sulfophenyl)xanthine)
Trials
(1,3-dipropyl-8-(4-sulfophenyl)xanthine)
Recent Studies (post-2010) (1,3-dipropyl-8-(4-sulfophenyl)xanthine)
1000108013

Protein Interaction Comparison

ProteinTaxonomybw a522 (IC50)1,3-dipropyl-8-(4-sulfophenyl)xanthine (IC50)
Adenosine receptor A1Rattus norvegicus (Norway rat)0.12
Adenosine receptor A1Bos taurus (cattle)0.0034

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobson, KA; Ji, XD; Kim, HO; Melman, N; Olah, ME; Stiles, GL1

Other Studies

1 other study(ies) available for bw a522 and 1,3-dipropyl-8-(4-sulfophenyl)xanthine

ArticleYear
Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.
    Journal of medicinal chemistry, 1994, Sep-30, Volume: 37, Issue:20

    Topics: Adenosine; Adenylyl Cyclase Inhibitors; Animals; Brain; Brain Chemistry; Caffeine; CHO Cells; Cricetinae; Gene Expression; Iodine Radioisotopes; Molecular Structure; Phenethylamines; Phenylisopropyladenosine; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Transfection; Xanthines

1994